Clathrin heavy chain (CLTC) Mouse Monoclonal Antibody [Clone ID: BF-06]
CAT#: AM03115PU-N
Clathrin heavy chain (CLTC) mouse monoclonal antibody, clone BF-06, Purified
Need it in bulk or conjugated?
Get a free quote
CNY 3,940.00
货期*
5周
规格
Specifications
Product Data | |
Clone Name | BF-06 |
Applications | ELISA, FC, IF, IP, WB |
Recommend Dilution | Flow Cytometry: 2-5 µg/ml. Positive control: Human blood leukocytes. Immunoprecipitation. Western Blotting. Immunocytochemistry. ELISA. |
Reactivity | Bovine, Human, Mouse, Porcine, Rat |
Host | Mouse |
Clonality | Monoclonal |
Specificity | The antibody recognizes Clathrin heavy chain, an ubiquitously expressed 180 kDa protein involved in receptor-mediated endocytosis. |
Formulation | Stabilising Tris buffered saline (TBS) with 15 mM Sodium Azide, approx. pH 8.0 State: Purified State: Liquid purified Ig fraction (> 95% pure by SDS-PAGE) |
Concentration | lot specific |
Purification | Precipitation and Chromatography |
Conjugation | Unconjugated |
Storage Condition | Store the antibody at 2-8°C. Do not freeze. |
Gene Name | clathrin heavy chain |
Database Link | |
Background | Clathrin is a submembrane protein that polymerizes into coat-like lattices, which results in membrane invagination. The basic oligomers are composed of three clathrin heavy chain (180 kDa) and three light chain (30 kDa) subunits and the process of polymerization is dynamically regulated by the light chains. Interaction of clathrin with the plasma membrane is mediated by adaptor proteins (AP1-4) specific for different cellular compartments. Another proteins, such as endophilin, epsin and amphiphysin are involved in membrane invagination and clathrin rearrangements. Finally, dynamin functions at the fission stage of clathrin-mediated endocytosis. |
Synonyms | CLTC, CLH17, CLTCL2, KIAA0034, Membrane Vesicle Marker |
Reference Data | |
Protein Pathways | Endocytosis, Huntington's disease, Lysosome |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
其它Clathrin heavy chain产品
Customer
Reviews
Loading...